Thyrocare Technologies Limited (THYROCARE.BO)

INR 895.35

(2.05%)

Total Liabilities Summary of Thyrocare Technologies Limited

Thyrocare Technologies Limited's latest annual total liabilities in 2023 was 1.16 Billion INR , up 19.23% from previous year.
Thyrocare Technologies Limited's latest quarterly total liabilities in 2024 Q1 was - INR , down -100.0% from previous quarter.
Thyrocare Technologies Limited reported annual total liabilities of 975 Million INR in 2022, up 20.24% from previous year.
Thyrocare Technologies Limited reported annual total liabilities of 810.9 Million INR in 2021, down -31.58% from previous year.
Thyrocare Technologies Limited reported quarterly total liabilities of 1.08 Billion INR for 2024 Q2, down 0.0% from previous quarter.
Thyrocare Technologies Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Thyrocare Technologies Limited (2023 - 2012)

Historical Annual Total Liabilities of Thyrocare Technologies Limited (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	1.16 Billion INR	19.23%
2022	975 Million INR	20.24%
2021	810.9 Million INR	-31.58%
2020	1.18 Billion INR	13.98%
2019	1.03 Billion INR	162.58%
2018	396 Million INR	10.89%
2017	357.1 Million INR	18.95%
2016	300.21 Million INR	9.03%
2015	275.34 Million INR	63.55%
2014	168.35 Million INR	-57.35%
2013	394.68 Million INR	8.35%
2012	364.28 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	- INR	-100.0%
2024 Q2	1.08 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	1.05 Billion INR	0.0%
2023 FY	1.16 Billion INR	19.23%
2023 Q4	1.16 Billion INR	0.0%
2022 Q3	866.2 Million INR	10.95%
2022 Q1	- INR	-100.0%
2022 Q2	780.7 Million INR	0.0%
2022 FY	975 Million INR	20.24%
2022 Q4	975 Million INR	12.56%
2021 Q4	810.9 Million INR	-11.09%
2021 FY	810.9 Million INR	-31.58%
2021 Q2	1.01 Billion INR	-26.23%
2021 Q1	1.37 Billion INR	15.59%
2021 Q3	912 Million INR	-9.77%
2020 Q2	1.02 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q4	1.18 Billion INR	0.0%
2020 FY	1.18 Billion INR	13.98%
2019 Q1	- INR	-100.0%
2019 FY	1.03 Billion INR	162.58%
2019 Q4	1.03 Billion INR	0.0%
2019 Q2	779.2 Million INR	0.0%
2019 Q3	- INR	-100.0%
2018 Q2	392.1 Million INR	0.0%
2018 FY	396 Million INR	10.89%
2018 Q1	- INR	-100.0%
2018 Q4	396 Million INR	0.0%
2018 Q3	- INR	-100.0%
2017 Q2	348.84 Million INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	357.1 Million INR	0.0%
2017 FY	357.1 Million INR	18.95%
2017 Q1	- INR	-100.0%
2016 Q3	- INR	-100.0%
2016 Q2	382.09 Million INR	0.0%
2016 Q1	- INR	-100.0%
2016 FY	300.21 Million INR	9.03%
2016 Q4	300.21 Million INR	0.0%
2015 Q3	143.48 Million INR	-69.84%
2015 Q1	- INR	0.0%
2015 FY	275.34 Million INR	63.55%
2015 Q4	275.34 Million INR	91.9%
2015 Q2	475.76 Million INR	0.0%
2014 FY	168.35 Million INR	-57.35%
2013 FY	394.68 Million INR	8.35%
2012 FY	364.28 Million INR	0.0%

Peer Total Liabilities Comparison of Thyrocare Technologies Limited

Name	Total Liabilities	Total Liabilities Difference
Krsnaa Diagnostics Limited	3.62 Billion INR	67.897%
Dr. Lal PathLabs Limited	5.7 Billion INR	79.627%
Metropolis Healthcare Limited	4.55 Billion INR	74.495%
Vijaya Diagnostic Centre Limited	3.22 Billion INR	63.992%
Vimta Labs Limited	803.54 Million INR	-44.672%